Australia and Oceania: Market for Medicaments Containing Corticosteroid Hormones 2024

Market Size for Medicaments Containing Corticosteroid Hormones in Australia and Oceania

The medicaments containing corticosteroid hormones market in Australia and Oceania rose rapidly to $X in 2021, with an increase of 5.3% against the previous year. The total consumption indicated a slight expansion from 2012 to 2021: its value increased at an average annual rate of +1.1% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, consumption decreased by -10.9% against 2019 indices. Over the period under review, the market hit record highs at $X in 2019; however, from 2020 to 2021, consumption remained at a lower figure.

Production of Medicaments Containing Corticosteroid Hormones in Australia and Oceania

In value terms, medicaments containing corticosteroid hormones production surged to $X in 2021 estimated in export price. Over the period under review, production posted a significant expansion. The pace of growth appeared the most rapid in 2017 when the production volume increased by 473%. Over the period under review, production reached the peak level at $X in 2019; however, from 2020 to 2021, production stood at a somewhat lower figure.

Exports of Medicaments Containing Corticosteroid Hormones

Exports in Australia and Oceania

In 2021, the amount of medicaments containing corticosteroid hormones exported in Australia and Oceania surged to X tons, jumping by 18% on 2020. Over the period under review, exports posted a strong increase. The growth pace was the most rapid in 2017 with an increase of 211%. Over the period under review, the exports attained the peak figure in 2021 and are expected to retain growth in the immediate term.

In value terms, medicaments containing corticosteroid hormones exports contracted to $X in 2021. Overall, exports enjoyed a significant increase. The growth pace was the most rapid in 2017 with an increase of 326%. The level of export peaked at $X in 2018; however, from 2019 to 2021, the exports failed to regain momentum.

Exports by Country

In 2021, Australia (X tons) was the largest exporter of medicaments containing corticosteroid hormones in Australia and Oceania, creating 99% of total export.

Australia was also the fastest-growing in terms of the medicaments containing corticosteroid hormones exports, with a CAGR of +17.4% from 2012 to 2021. While the share of Australia (+4.7 p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Australia ($X) also remains the largest medicaments containing corticosteroid hormones supplier in Australia and Oceania.

In Australia, medicaments containing corticosteroid hormones exports expanded at an average annual rate of +22.0% over the period from 2012-2021.

Export Prices by Country

The export price in Australia and Oceania stood at $X per ton in 2021, which is down by -16% against the previous year. Overall, the export price, however, showed notable growth. The pace of growth was the most pronounced in 2016 an increase of 44% against the previous year. Over the period under review, the export prices hit record highs at $X per ton in 2018; however, from 2019 to 2021, the export prices stood at a somewhat lower figure.

As there is only one major export destination, the average price level is determined by prices for Australia.

From 2012 to 2021, the rate of growth in terms of prices for Australia amounted to +4.0% per year.

Imports of Medicaments Containing Corticosteroid Hormones

Imports in Australia and Oceania

In 2021, purchases abroad of medicaments containing corticosteroid hormones increased by 4.4% to X tons, rising for the second year in a row after three years of decline. In general, imports, however, saw a pronounced descent. The most prominent rate of growth was recorded in 2013 when imports increased by 8.4% against the previous year. As a result, imports reached the peak of X tons. From 2014 to 2021, the growth of imports remained at a somewhat lower figure.

In value terms, medicaments containing corticosteroid hormones imports rose to $X in 2021. Overall, imports, however, recorded a relatively flat trend pattern. The growth pace was the most rapid in 2017 with an increase of 23% against the previous year. Over the period under review, imports reached the peak figure at $X in 2013; however, from 2014 to 2021, imports failed to regain momentum.

Imports by Country

In 2021, Australia (X tons) represented the main importer of medicaments containing corticosteroid hormones, generating 81% of total imports. It was distantly followed by New Zealand (X tons), achieving an 11% share of total imports. Papua New Guinea (X tons) and Fiji (X tons) took a little share of total imports.

From 2012 to 2021, average annual rates of growth with regard to medicaments containing corticosteroid hormones imports into Australia stood at -1.2%. At the same time, Papua New Guinea (+11.1%) displayed positive paces of growth. Moreover, Papua New Guinea emerged as the fastest-growing importer imported in Australia and Oceania, with a CAGR of +11.1% from 2012-2021. By contrast, New Zealand (-4.0%) and Fiji (-16.5%) illustrated a downward trend over the same period. While the share of Australia (+7.1 p.p.) and Papua New Guinea (+2.1 p.p.) increased significantly in terms of the total imports from 2012-2021, the share of New Zealand (-2 p.p.) and Fiji (-7.4 p.p.) displayed negative dynamics.

In value terms, Australia ($X) constitutes the largest market for imported medicaments containing corticosteroid hormones in Australia and Oceania, comprising 89% of total imports. The second position in the ranking was held by New Zealand ($X), with a 9.6% share of total imports. It was followed by Papua New Guinea, with a 0.6% share.

In Australia, medicaments containing corticosteroid hormones imports remained relatively stable over the period from 2012-2021. In the other countries, the average annual rates were as follows: New Zealand (-1.1% per year) and Papua New Guinea (+1.9% per year).

Import Prices by Country

In 2021, the import price in Australia and Oceania amounted to $X per ton, remaining constant against the previous year. Import price indicated a slight increase from 2012 to 2021: its price increased at an average annual rate of +1.6% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, medicaments containing corticosteroid hormones import price increased by +67.5% against 2016 indices. The most prominent rate of growth was recorded in 2018 an increase of 23% against the previous year. The level of import peaked in 2021 and is expected to retain growth in the near future.

There were significant differences in the average prices amongst the major importing countries. In 2021, the country with the highest price was Australia ($X per ton), while Fiji ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Fiji (+7.6%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :